News

Deal Announcements

Sapheon Secures Series B Venture Capital Round

Monday, August 27, 2012 5:36:00 AM PDT | VentureDeal
Santa Rosa, California  --  Medical device company Sapheon has raised $18.5 million in its second round of institutional venture capital investment.

Sapheon says that its mission is to develop "new approaches and disruptive technologies for the treatment of vascular disease."

Millennium Life Sciences Fund and undisclosed investors made the investment.

The company said it will use the proceeds to complete a randomized clinical trial.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1